Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05874635Not ApplicableActive Not Recruiting

Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

Role: lead

NCT05121844Not ApplicableActive Not Recruiting

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform

Role: lead

NCT06214221Not ApplicableActive Not Recruiting

Using Signos mHealth Platform in Adults for Weight Management

Role: lead

All 3 trials loaded